Tag: EML4-ALK; ALK,Press Releases,norgen biotek
-
Norgen Biotek Corp. Announces Supply Agreement with Biodesix Enabling the First EML4-ALK Liquid Biopsy Test with Results in 72-Hours
Norgen Biotek Corp., an innovative Canadian biotechnology company focusing on advancing powerful tools for DNA, RNA and protein stabilization and purification, today announced the signing of a supplier agreement with Biodesix, Inc. to supply novel sample preparation products based on Norgen Biotek’s proprietary purification technology. Biodesix, Inc. is a U.S.-based company that discovers and commercializes…